Laboratorios Farmaceuticos ROVI SA
Madrid: ROVI
▼
51.45
-0.60
-1.15%
1 Day
-
Open
52.00
-
Previous Close
52.05
-
Volume (Avg)
46.79k (146.61k)
-
Day's Range
50.65-52.00
-
52Wk Range
44.20-74.90
-
Market Cap.
2.81B
-
Dividend Rate (Yield)
0.96 (1.84%)
-
Beta
-
-
Shares Outstanding
-
-
P/E Ratio (EPS)
15.56 (-)
Top Stories
-
Laboratorios Farmaceuticos ROVI SA
Reuters 6 days agoLaboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization ...
-
Laboratorios Farmaceuticos Rovi SA Stock Quote 0ILL
Morningstar%2c Inc. -
Laboratorios Farmaceuticos Rovi S.A.
Barron's -
Factors that might predict the Laboratorios Farmaceuticos Rovi SA share price direction
Yahoo Finance -
ROVI lidera Sustainalytics en la industria farmacéutica mundial
CompromisoRSE 6 days ago -
ROVI aumenta un 58% su beneficio en el primer semestre de 2022
elglobal -
Heparin Market Size to Grow by USD 2.29 billion, 37% of Market Growth to Originate from Europe - Technavio
Benzinga.com -
Moderna acuerda con Rovi suministro de vacuna contra covid-19
Yahoo Finanzas -
Heparin Sales Market Industry Report Analysis, Geographical Scope, Growth Tactics, And Forecast By 2031
Middle East North Africa Financial Network -
Moderna informa retrasos de socios de fabricación extranjeros
Yahoo Finanzas -
Laboratorios Farmaceuticos Rovi SA Stock News
Morningstar%2c Inc. -
Laboratorios Farmaceuticos Rovi S.A.
Barron's -
Heparin Market Size to Grow by USD 2.29 billion, 37% of Market Growth to Originate from Europe - Technavio
Longview News-Journal -
Laboratorios Farmaceuticos ROVI SA
CNBC -
Heparin Market Size to Grow by USD 2.29 billion, 37% of Market Growth to Originate from Europe - Technavio
Yahoo Finance 7/28/2022Driver and Challenge 11.3 Aspen Pharmacare Holdings Ltd. 11.4 Baxter International Inc. 11.5 Eisai Co. Ltd. 11.6 Fresenius SE and Co. KGaA 11.7 Hikma Pharmaceuticals Plc 11.8 Laboratorios Farmaceuticos Rovi SA 11.9 Nanjing Kingfriend Biochemical ...
